Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient

Vionnet, Julien; Pascual, Manuel; Testoni, Barbara; Combet, Christophe; Godat, Sébastien; Vijgen, Sandrine Elisabeth V; Aubert, Vincent; Rubbia-Brandt, Laura; Zoulim, Fabien; Moradpour, Darius

doi:10.1002/hep.29528

Scientific article

English

Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient

ContributorsVionnet, Julien; Pascual, Manuel; Testoni, Barbara; Combet, Christophe; Godat, Sébastien; Vijgen, Sandrine Elisabeth V; Aubert, Vincent; Rubbia-Brandt, Laura; Zoulim, Fabien; Moradpour, Darius

Published inHepatology

Publication date2017

Abstract

Direct-acting antivirals (DAAs) have changed the landscape of hepatitis C virus (HCV) treatment, but chronic hepatitis C (CHC) remains a leading indication for liver transplantation (LT). Hepatitis B virus (HBV) reactivation has been reported in HBV-HCV-coinfected patients treated with DAAs. We report on a case of late HBV reactivation after DAA-based treatment of recurrent hepatitis C in an antibody against hepatitis B core antigen (anti-HBc)-positive LT recipient. (Hepatology 2017).

Affiliation

Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie

Research group

Métastases du foie (657)

Citation (ISO format)

VIONNET, Julien et al. Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient. In: Hepatology, 2017. doi: 10.1002/hep.29528

Article (Published version)

Identifiers

PID : unige:101478
DOI : 10.1002/hep.29528
PMID : 28921620

ISSN of the journal0270-9139

427views

0downloads

Creation01/18/2018 2:30:00 PM

First validation01/18/2018 2:30:00 PM

Update time03/15/2023 7:45:54 AM

Status update03/15/2023 7:45:54 AM

Last indexation01/17/2024 2:04:37 AM

Archive ouverte UNIGE

Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient

Technical informations